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ABSTRACT
Objective: To verify how efficient respiratory parameters are in the follow-up of subjects 
with amyotrophic lateral sclerosis (ALS) and to observe possible correlations between 
respiratory and nutritional functions. Method: Sixteen patients with probable or defined 
ALS were selected and evaluated over eight months using the following respiratory 
parameters: spirometry, maximum inspiratory pressure (MIP), maximum expiratory pressure 
(MEP), arterial gasometry and pulse oximetry; and nutritional parameters such as body mass 
index (BMI) and percentage weight loss. Results: PaCO2 was a significant parameter to 
follow up disease evolution (p=0.051). There was significant correlation between MIP and 
MEP (r: 0.83); BMI and MIP (r: 0.70); BMI and MEP (r: 0.72); pulse oximetry and forced vital 
capacity (r: 0.57). Conclusion: PaCO2 was shown to be an efficient and significant parameter 
in the measurement of respiratory impairment; the correlations among MIP, MEP and BMI 
indicated that these are significant parameters for periodic clinical evaluation. 
Key words: amyotrophic lateral sclerosis, maximum inspiratory pressure, maximum 
expiratory pressure, body mass index.
Esclerose lateral amiotrófica: estudo prospectivo de parâmetros respiratórios 
RESUMO
Objetivo: Verificar a eficácia dos parâmetros respiratórios na evolução de indivíduos 
com esclerose lateral amiotrófica (ELA) e identificar possíveis correlações entre função 
respiratória e nutricional. Método: 16 pacientes com diagnóstico provável ou definido 
de ELA foram selecionados por critérios definidos e avaliados, durante 8 meses, através 
de parâmetros respiratórios: espirometria, pressão inspiratória máxima (PIM), pressão 
expiratória máxima (PEM), gasometria arterial e oximetria de pulso; e parâmetros 
nutricionais: índice de massa corporal (IMC) e porcentagem de perda de peso. Resultados: 
PaCO2 foi um parâmetro significativo para acompanhar a evolução da doença (p=0.051). 
Houve correlação significante entre PIM e PEM (r: 0.83); IMC e PIM (r: 0.70); IMC e PEM 
(r: 0.72); oximetria de pulso e capacidade vital forçada (r: 0.57). Conclusão: PaCO2 foi 
marcador eficaz e significante para medir o comprometimento respiratório; correlações 
entre PIM, PEM e IMC indicaram ser bons parâmetros nas avaliações clínicas periódicas.
Palavras-chave: esclerose lateral amiotrófica, pressão inspiratória máxima, pressão 
expiratória máxima, índice de massa corporal.Correspondence
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Amyotrophic lateral sclerosis (ALS) 
is a degenerative disease that affects mo-
tor neurons in the brain and spinal cord. 
Clinical characteristics include limb weak-
ness, difficulties in swallowing, speaking 
and breathing1. 
Bulbar dysfunction, resulting from le-
sions in either the corticobulbar tract or 
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motor nuclei, increases the risk of aspiration pneumonia, 
aggravating the respiratory function, which is sometimes 
already impaired. Swallowing dysfunction leads to nutri-
tional deficiency and consequently to a morbid spiral that 
increases respiratory muscle fatigue2. Nutritional status 
is aggravated unless it is routinely monitored in order to 
identify when a patient shows weight loss and malnutri-
tion3. Early intervention helps to delay morbidity. 
This study was aimed at evaluating how efficient re-
spiratory parameters are in the assessment of ALS evo-
lution, as well as observing possible correlations between 
respiratory and nutritional functions. 
METHOD
Patients with defined or probable ALS, according to 
the revised El Escorial, 19984, were followed up at the out-
patient clinic for Neuromuscular Diseases of the Universi-
ty of Campinas (UNICAMP), and participated in a cross-
sectional study with respiratory and nutritional evalua-
tion (first evaluation) and a longitudinal prospective study 
for eight months, during which respiratory parameters 
were observed. All the patients were in use of Riluzole 
and were sporadic cases. Those patients requiring assist-
ed mechanical ventilation or with a nasogastric tube or 
gastrotomy at the beginning of the study were excluded. 
The ethics committee of the School of Medical Sci-
ences - UNICAMP approved the study and all patients 
signed an informed consent form (protocol 347/2006).
In the initial evaluation, named the first evaluation, 
patients were assessed using spirometry; maximum in-
spiratory pressure (MIP), maximum expiratory pressure 
(MEP), gasometry and pulse oximetry. Three subsequent 
evaluations every two months included the same tests, 
except for spirometry.
Spirometry was carried out in the seated position, and 
included measurement of forced vital capacity (FVC) and 
peak expiratory flow (PEF) expressed as percentages of 
the predicted value, according to sex and age. 
Maximum inspiratory pressure and maximum expira-
tory pressure: MIP and MEP measurements were carried 
out, in accordance with Black and Hyatt, and based on the 
residual volume and total pulmonary capacity, respective-
ly, at three consecutive moments, with a 30-second inter-
val between maneuvers. The highest value was considered.
Arterial gasometry: partial arterial oxygen pressure 
(PaO2) <83 mmHg and partial arterial carbonic gas pres-
sure (PaCO2) >45 mmHg were considered abnormal6. 
Pulse oximetry was measured using a Moryia 1001 
model oximeter.
Symptoms of respiratory muscle weakness: dyspnoea 
on exertion, morning headaches, fatigue, disturbed sleep 
(insomnia, excessive daytime somnolence, nocturia, 
impatience)7..
Body mass index (BMI): BMI=body mass kg/height m2; a 
value between 18.5 and 24.9 kg/m2 was considered normal 8.
Percentage weight loss (WL%) was determined by 
comparing usual and current patient weight. Weight loss 
of 10% indicated malnutrition and above 10% indicated 
severe malnutrition9.
Body mass index and percentage of weight loss were 
measured in the first evaluation.
Statistical analysis
In order to compare the evolution of continuous vari-
ables, the analysis of variance (ANOVA) was used for re-
peated measurements with Rank transformation. Correla-
tions between variables were found using Spearman’s co-
efficient. Values were classified as: 0 to 0.19 – weak corre-
lation; 0.2 to 0.39 – mild correlation; 0.4 to 0.59 – moder-
ate correlation; 0.6 to 0.79 – important correlation; 0.8 to 
1 – almost perfect correlation10. The Statistical Analysis 
System (version 9.1.3) and Microcal Origin software (ver-
sion 5.0) were used. A significance level was p≤0.05.
RESULTS
Table 1 shows the demographic data of the patients; 
four cases (2, 5, 6 and 9) had predominant bulbar ALS and 
12 had predominant appendicular ALS. Thirteen male pa-
tients and three females were within normal range of pul-
monary function test parameters, pulse oximetry and ar-
terial gasometry. The MIP reached 49% of what was ex-
pected, according to the patients’ sex and age and the 
MEP was 34.7%, indicating restrictive muscle impairment.
The mean BMI for patients subjected to the test (n=10) 
was 22.54, which is within normal range, although WL% 
indicated that three patients were nutritionally at-risk, five 
had severe malnutrition and two had gained body mass 
(patients 1 and 8, Table 1). The mean WL% was 13.3%.
Five out of 16 patients evaluated for PaCO2 succeed-
ed in carrying out the tests on a continuous basis in the 
first, second and fourth evaluations. In these patients, the 
mean values of PaCO2 ranged between 34.74 in the first 
evaluation and 39.12 mmHg in the last one, with statisti-
cal relevance (p=0.0513) (Figure). The mean PaO2 of these 
patients ranged between 87.16 in the first evaluation and 
89.18 mmHg in the last one, with no statistical relevance 
(p=0.7504). 
Maximum inspiratory pressure was evaluated four 
times in 15/16 patients and MEP in 14/16. The MIP mean 
ranged between –65.67 cmH2O (first exam) and –64.33 
cmH2O (fourth exam); this decrease was not significant 
(p=0.7764). The MEP mean ranged between 74.29 cmH2O 
and 71.79 cmH2O, also with no significance (p=0.7671). 
The MIP and MEP values showed high variability and 
great standard deviation. 
The mean values of pulse oximetry showed slight vari-
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ation in the 16 patients: 95.25% in the first evaluation and 
95.13% in the last one, with no significant statistical vari-
ance (p=0.1816).
Strong correlation between MIP and MEP was ob-
served (r: 0.83500; p=0.0002). Body mass index strongly 
Table 1. Descriptive variables in the first evaluation.
Cases Age Sex MIP MEP Oxi%
Spirometry Gasometry
BMI %WLFVC% PEF% PaO2 PaCO2
1 59 M –55 50 97 98 114 93.1 34.6 25.1 –15.4
2 40 F –10 nap 95 nap nap 91.2 37.2 18.2 14.3
3 49 M –45 40 94 60 59 102 38.4 18.1 26.4
4 46 M –135 130 96 109 103 61 29.1 24.2 14.6
5 32 F –10 10 86 54 47 134 29 19.5 7.4
6 42 M –45 30 97 nap nap 79 37 19.9 21.8
7 53 M –110 95 98 87 78 85.7 30.2 27 2.1
8 44 M –100 80 99 96 104 89.6 35.8 24.4 –1.2
9 37 M –35 45 97 nap nap 92 38 21.3 8.7
10 36 M –60 80 94 80 95 73 36 27.7 11.1
11 52 M np np 96 np np 70.7 38.6 – –
12 62 F –70 60 92 80 92 75.1 33.6 – –
13 41 M –30 60 96 52 49 75 42 – –
14 49 M –110 125 96 91 86 86.9 39.5 – –
15 43 M –45 85 96 102 102 109 33 – –
16 35 M –125 150 95 76 73  np np  – –
Mean 45 – 65.66 74.28 95.25 82.08 83.5 87.82 35.46
SD 8.4 – 40.78 40.32 2.97 18.82 22.45 17.89 3.87
Median 44.5 – 55 70 96 52 47 86.9 36
Min 32 – 10 10 86 83.5 89 61 29
Max 62 – 135 150 99 109 114  134 42    
M: male; F: female; MIP: maximum inspiratory pressure; MEP: maximum expiratory pressure; Oxi: Pulse oximetry; FVC%: percentage of forced vital capacity; PEF%: 
peak expiratory flow percentage; PaO2: partial arterial oxygen pressure; PaCO2: partial arterial carbonic gas pressure; BMI: body mass index; %WL: percentage 
weight loss; nap: not able to perform the test; np: test not performed. 











Figure. Mean and standard deviation of PaCO2 evolution in the 
three evaluations. ANOVA Test, p-value=0.0513.
Table 2. Spearman’s correlation coefficient between respiratory 
and nutritional parameters 
 BMI %WL MIP MEP
PaO2 –0.527 –0.224 –0.50222 –0.44904
PaO2 0.117 0.53 0.0672 0.1237
n 10 10 14 13
PaCO2 –0.418 –0.491 –0.26549 –0.15152
PaCO2 0.229 0.15 0.3589 0.6212
n 10 10 14 13
Oxi 0.443 –0.474 0.23863 0.13887
Oxi 0.2 0.166 0.3917 0.6359
n 10 10 15 14
MIP 0.70123 –0.17683 – 0.83500
MIP 0.0239 0.6250 – 0.0002
n 10 10 – 14
MEP 0.72804 –0.23431 – –
MEP 0.0262 0.5440 – –
n 9 9 – –
PaO2: partial arterial oxygen pressure; PaCO2: partial arterial carbonic gas 
pressure; Oxi: pulse oximetry; MIP: maximum inspiratory pressure; MEP: 
maximum expiratory pressure; BMI: body mass index; %WL: percentage 
weight loss; n: number of patient.
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correlated with MIP (r: 0.7012; p=0.0239) and with MEP 
(r: 0.7280; p=0.0262), with no significance in other com-
parisons (Table 2).
There was moderate significance in correlation between 
pulse oximetry and FVC values (r: 0.5768; p=0.0496), 
with no significance in other comparisons (Table 3).
DISCUSSION
PaCO2 proved to be an efficient indicator in the eval-
uation of respiratory impairment throughout the eight 
months. There was an increase in the mean values, even 
though they remained within the normal range, that is, 
lower than 45 mmHg. Lyall et al.11 reported that PaCO2 
is one of the main parameters used as an indication for 
starting noninvasive mechanical ventilation in ALS, al-
though it is not very sensitive due to the late manifesta-
tion of hypercapnia. It can be supposed that as the dis-
ease evolves, hypercapnia may trigger a vicious cycle of 
pulmonary function worsening and the necessity of ven-
tilation support. 
Lyall et al.11 recruited 81 patients with ALS to evalu-
ate their hypercapnia as a respiratory function complica-
tion prognosticator. The PaCO2 mean was 41.7 mmHg 
and only 18% of the subjects had hypercapnia. The au-
thors reported that in the presence of a mild weakness, 
PaCO2 drops below normal levels and hyperventilation 
occurs to compensate for alveolar hypoxemia. 
According to the American Academy of Neurology 
there is a lack of evidence of the best parameter to detect 
respiratory failure. There are no previous studies that eval-
uate the relationship between respiratory muscle strength 
and ventilation failure in large samples of ALS patients12. 
In this study, arterial gasometry and pulse oximetry 
values remained normal during the eight-month follow-
up. The MIP and MEP values were 60% below what was 
expected after the first evaluation, which already indicates 
the beginning of respiratory muscle impairment 5 even 
though the data was not statistically significant. 
It is a common belief that PaCO2, together with pul-
monary hypoventilation signs, may indicate a respirato-
ry impairment throughout time, and that it is an indica-
tor for preventive procedures such as, for instance, the 
use of noninvasive ventilation support7.
Vital capacity is one of the most used clinical tests 
to monitor pulmonary function13. Patients with severe 
restrictive ventilation impairment resulting from neu-
romuscular diseases show a more significant reduction 
of pulmonary volume than maximum pressures. There-
fore, vital capacity is a more sensitive measurement in the 
evaluation of respiratory muscle strength in the advanced 
stage of these diseases14 .
Jackson et al.15, in their studies on pulmonary function 
in ALS, reported that most of the patients, even though 
their FVC was 70% above expected, had MIP lower than 
60 cm H2O, which may reflect an early respiratory in-
sufficiency. Our study corroborates that, since the FVC 
mean was 82% of the expected value and the MIP mean 
was 49% of what was expected. 
Pulse oximetry was carried out during outpatient clin-
ical evaluations, and it was not possible to monitor our 
patients during nights. Even so, there was a positive cor-
relation between oximetry and FVC, demonstrating the 
importance of evaluating respiratory parameters on a reg-
ular basis. 
Dysfunction of inspiratory, expiratory and bulbar mus-
cles may result in oxygen desaturation due to hypercapnia, 
coughing dysfunction and excessive aspiration of saliva. 
In those conditions, noninvasive ventilation support helps 
to normalize PaCO2 values and oxygen desaturation16.
There was no correlation between pulse oximetry and 
arterial gasometry, probably because patients had not yet 
shown severe respiratory impairment, with hypercapnia 
and symptoms of respiratory muscle weakness such as 
dyspnea on effort, fatigue, morning headache or sleep dis-














 n 11 11
PaCO2 –0.34169 –0.10909
PaCO2 0.3037 0.7495







MIP: maximum inspiratory pressure; MEP: maximum expiratory pressure; Oxi: 
pulse oximetry; PaO2: partial arterial oxygen pressure; PaCO2: partial arterial 
carbonic gas pressure; BMI: body mass index; %WL: percentage weight 
loss; FVC%: percentage of forced vital capacity; PEF%: peak expiratory flow 
percentage; n: number of patient.
Arq Neuropsiquiatr 2010;68(2)
262
Amyotrophic lateral sclerosis: respiratory parameters 
Almeida et al.
orders. Constant measurement of oxygen saturation is 
assumed to be necessary to decide what is the ideal mo-
ment to start noninvasive mechanical ventilation when a 
patient complains of what is evidence of nocturnal pul-
monary hypoventilation. 
Lyall et al.11 demonstrated significant correlation be-
tween PaCO2 and MIP and MEP. The low values obtained 
in respiratory muscle strength tests led to hypercapnia. 
Hypercapnia occurs when weakness becomes severe, lead-
ing to ventilation failure. As no correlation between these 
parameters was found, it is assumed that weakness of re-
spiratory muscles in our patients was mild to moderate. 
Just like Lechtzin17, we assume it is a wise procedure 
to measure PaCO2 when spirometry is unable to explain 
symptoms of respiratory complications in patients or if 
they report sleeping difficulties. 
The most significant correlation of BMI and respiratory 
parameters was between MIP and MEP, in which patients 
with greater weakness and reduced body mass showed re-
duced respiratory muscular strength. There was no corre-
lation between BMI and spirometry since the patients pre-
sented with normal values for FVC and spirometry. This 
is probably because spirometry is not sensitive enough to 
evaluate ventilation function in initial or moderate stages of 
respiratory discomfort, as reported by Schoesmith et al.18.
The results found in this study corroborate those ob-
tained by Silva et al.19 who also found correlation be-
tween BMI and FVC and between BMI and MEP in pa-
tients who presented with bulbar ALS. The correlation 
was strong, even considering MIP and MEP indicators 
are not a sensitive measure in the evaluation of the respi-
ratory function in these patients, due to oro-pharyngeal 
weakness, as described by Fitting et al.20. 
Desport et al. 21 evaluated nutritional status through 
the use of BMI in ALS patients. In their study, the surviv-
al rate time was shorter in malnourished patients when 
compared to the group considered as normal. The nu-
tritional status was a decisive factor for survival, as a vi-
tal capacity 60% higher than the expected value. Howev-
er, both measurements were considered as independent 
prognostic values. 
In the patients that had BMI assessed, the FVC mean 
was 83.4% of the predicted value. Only two out of the 10 
patients who had their BMI evaluated in the first visit had 
values below normal. When evaluated by WL%, five pa-
tients showed severe malnutrition, in other words, a loss 
greater than 10%, according to Mahan and Stump9 val-
ues. Rio and Cawadias3 suggest that body weight to eval-
uate nutritional status in ALS patients should not be un-
derestimated; however, impaired mobility may be a lim-
itation in the measurement of this parameter. Nutrition-
al support may delay weight loss and muscular atrophy. 
Studies have demonstrated that body weight loss associ-
ated with bulbar changes (dysphagia and breathing) re-
quires early and specific nutritional support22.
The intervention of the multidisciplinary team, such 
as physicians, physiotherapists, nutritionists and speech 
therapists, is necessary to evaluate the patient as a whole. 
A more comprehensive healthcare protocol allows the pa-
tient an improved quality of life. 
In conclusion, PaCO2 was shown to be an efficient and 
significant parameter to in the measurement of respira-
tory impairment. The correlations among MIP, MEP and 
BMI indicated that these are significant parameters for 
periodic clinical evaluation. 
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